Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Role Summary:
The Associate Director, Financial Planning & Analysis (FP&A) provides financial planning, reporting, business insights, and analytical support across the organization. The Associate Director serves as a strategic business partner and finance systems leader, owning the administration, optimization, and evolution of FP&A reporting tools, planning applications, and financial data warehouse capabilities. This role partners closely with Accounting, IT, and business stakeholders to deliver scalable financial reporting, forecasting, and analytics solutions that improve transparency and support data-driven decision making. The Associate Director develops financial models, analyzes business performance and trends, and delivers actionable insights that support operational execution, portfolio investment decisions, resource allocation, and long-term growth strategies.
This position is based in Waltham, MA.
Primary Responsibilities Include:
Financial Planning, Forecasting & Analysis
- Collaborate with cross-functional teams to develop quarterly forecasts, annual budgets, and short- and long-range financial plans.
- Monitor budget versus actual performance and provide variance analysis, insights, and recommendations to business leaders.
- Build and maintain financial models to support KPI analysis, portfolio prioritization, commercial strategy, and investment decisions.
- Conduct scenario planning and investment analyses, including evaluation of resource allocation and buy-up investment opportunities.
- Perform balance sheet, P&L, cash flow, COGS, and CAPEX/fixed asset analyses to support operational and strategic decision making.
Financial Systems, Reporting & Business Intelligence
- Lead the development, enhancement, and ongoing management of FP&A systems, reporting tools, and financial data warehouse capabilities.
- Create and maintain financial dashboards that provide visibility into actual spending, purchase order commitments, and forecast assumptions.
- Partner with Accounting and IT to improve financial reporting processes and integrate financial data across enterprise systems.
- Develop automated reporting and analytics solutions that enable stakeholders to access timely, actionable financial insights.
- Ensure data integrity, consistency, and usability across financial planning and reporting platforms.
Business Partnership & Governance
- Serve as a trusted financial partner to functional leaders by providing actionable insights and recommendations that support business objectives.
- Review contracts and purchase requisitions to ensure alignment with approved budgets, financial policies, and forecast assumptions.
- Monitor and report on key performance indicators (KPIs) and business performance metrics.
- Support strategic and operational decision making through ad hoc financial analyses and business case development.
Strategic Initiatives & Continuous Improvement
- Assist in the preparation of financial materials for Audit Committee and Board of Directors meetings.
- Identify opportunities to improve financial processes, reporting efficiency, data quality, and planning capabilities.
- Lead or support cross-functional initiatives that enhance forecasting accuracy, operational effectiveness, and financial visibility.
- Drive continuous improvement through the implementation of scalable financial processes, systems, and analytics solutions.
Education and Skills Requirements:
- Bachelor’s degree in Finance, Accounting, Economics, Business Administration, or a related discipline; MBA, CPA, or other advanced degree/certification preferred.
- 8+ years of progressive experience in FP&A, corporate finance, business analysis, or related financial roles, preferably within biotechnology, pharmaceuticals, life sciences, or a growth-stage public company environment.
- Demonstrated experience supporting annual budgeting, forecasting, long-range planning, and financial reporting processes.
- Expertise in financial modeling, scenario analysis, variance analysis, and business performance management.
- Experience administering and optimizing financial planning, reporting, business intelligence, and enterprise financial systems.
- Experience working with financial data warehouses and partnering with IT teams on reporting and systems enhancement initiatives.
- Strong understanding of financial statements, including P&L, balance sheet, and cash flow analysis.
- Experience partnering effectively with Accounting, IT, and business stakeholders to deliver integrated financial solutions.
- Strong analytical, problem-solving, and critical-thinking skills with the ability to translate complex financial information into actionable business insights.
- Excellent communication and presentation skills with the ability to influence and build alignment across functions.
- Demonstrated ability to manage multiple priorities, lead process improvements, and drive results in a fast-paced environment.
- Advanced proficiency with Microsoft Excel and financial planning/reporting systems.
- Operates with sound judgment, accountability, and a collaborative approach while influencing cross-functional initiatives and supporting organizational objectives.
#LI-Onsite
The pay range reflects the base pay range Dyne reasonably expects to pay for this role at the time of posting. Individual compensation depends on factors such as education, experience, job-related knowledge, and demonstrated skills.
The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.
Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
Skills Required
- Bachelor's degree in Finance, Accounting, Economics, Business Administration, or related discipline
- 8+ years progressive experience in FP&A, corporate finance, business analysis, or related financial roles
- Experience supporting annual budgeting, forecasting, long-range planning, and financial reporting processes
- Expertise in financial modeling, scenario analysis, variance analysis, and business performance management
- Experience administering and optimizing financial planning/reporting systems and developing financial data warehouse capabilities
- Advanced proficiency with Microsoft Excel
- Strong understanding of financial statements (P&L, balance sheet, cash flow) and analyses (COGS, CAPEX, fixed assets)
- Experience partnering with Accounting, IT, and business stakeholders to deliver integrated financial solutions
- Excellent communication and presentation skills with ability to influence cross-functionally and prepare board-level materials
- MBA, CPA, or other advanced degree/certification
- Experience in biotechnology, pharmaceuticals, life sciences, or growth-stage public company environments
What We Do
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue seen with other approaches. Dyne has a broad portfolio of programs for serious muscle diseases, including candidates for myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com.
